Endosphères Therapy®
Endosphères Therapy®
Endosphères Therapy® was devised and crafted in Italy.
It is now available worldwide to provide clients with one treatment that delivers multiple results for the face and body.
Endosphères Therapy® is a technology that uses an innovative Compressive Microvibration™ system, a treatment that, through a roller device composed of 55 silicon spheres, generates low-frequency mechanical vibrations.
The Endosphères Therapy® method has been enriched with the sensor system, a pressure controlled mechanism, which allows it to accurately assess the amount of pressure applied in relation to the type of tissue and the number of sessions already completed.
The treatment has many benefits, including: reducing the appearance of cellulite, improving local blood circulation, enhancing lymphatic drainage, relieving minor muscle aches and pains, and aiding in muscle recovery post workout.
The Endosphères Therapy® has clinically proven results from reputable universities and medical institutions.
It’s 100% non-invasive with no downtime and a 97.8% client satisfaction rating!
BODY TREATMENTS: Endosphères Therapy can be used on the full body and allows you to target the areas of your body that you
would like to improve. The treatments address everything from rejuvenation, to reduction of cellulite, and muscle toning.
- REDUCES CELLULITE:
Cellulite affects 9 out of every 10 people – men and women. Cellulite occurs because of hypertrophy of fat cells and water retention. This is brought about by the presence of poor circulation. Endosphères Therapy reduces the appearance of cellulite by improving local blood circulation and smoothing the tissues of the problem areas. Working on the lymphatic system has been clinically proven to improve the appearance of cellulite.
- TIGHTENS & TONES SKIN:
Our Compressive Microvibration™ method works gently on the tissue to increase collagen and tone skin.
During a clinical trial of 656 patients, cellulite improved by 39% of the customer satisfaction rating was 97.8%.